Inactive Instrument

Press Releases BioPharmX Corp OTC Bulletin Board

Equities

US09072X1019

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

06/05	Second Revised Combined Joint Liquidation Plan and Disclosure Statement Approved for Trex Wind-down, Inc.	CI
04/04	First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals	24/01	AQ
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market	30/11	AQ
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American	29/11	AQ
Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance	19/23/19	AQ
Timber Pharmaceuticals : Announces NYSE Acceptance of Plan to Regain Listing Compliance - Form 8-K	19/23/19	PU
TIMBER PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Timber Pharmaceuticals, Inc. - TMBR	29/23/29	BU
Timber Pharmaceuticals : Why Is Skillz (SKLZ) Stock Up 20% Today	23/23/23	PU
LEO Pharma Signs Agreement to Acquire Timber Pharmaceutical	22/23/22	AQ
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTG, ESTE, PR, TMBR	22/23/22	PR
TMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to Shareholders	21/23/21	BU
Timber Pharmaceuticals to be Acquired by LEO Pharma	21/23/21	AQ
Timber Pharmaceuticals Discloses Communication From NYSE American	04/23/04	AQ
Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis	20/23/20	AQ
Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001	05/23/05	AQ
TIMBER PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	16/23/16	AQ
Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results	16/23/16	AQ
Timber Pharmaceuticals : GAAP EPS of -$9.19, revenue of $0.08M misses by $0.72M	03/23/03	PU
Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results	01/23/01	AQ
TIMBER PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	01/23/01	AQ
Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology	20/23/20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BioPharmX Corp OTC Bulletin Board

Equities

US09072X1019

Press Releases

Filters